A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
The Manchester spinout is seeking capital to launch its first product, a test that can detect the early-stage onset of an eye disease called age-related macular degeneration.
The university’s Capsula Studio has agreed to a strategic partnership with Pinnacle Industries to open an accelerator in Pune.
Indi Molecular meets Merck for $11.5m series A
The antibody replacement technology was co-developed by the California Institute of Technology.
Mirexus flexes muscles to raise $12m
Mirexus, a biomaterials spinout of Guelph, will use the funding to support a new production facility.
Germany awards funding to 48 institutions
The Federal Ministry of Education and Research has allocated capital to institutions such as University of Potsdam to bolster technology transfer activities.
Rebel Venture Fund responds to Echo
The student-led university venturing fund from University of Nevada, Las Vegas has committed capital to Echo Payment Systems.
Frontier IP has received a 20% stake in Molendotech, a new spinout of Plymouth University that has developed a way to test the purity of water.
UC Riverside launches $10m Highlander fund
The fund, first announced in October 2016, has been launched with $10m in capital to invest in spinouts and startups that emerge from the university or surrounding region.
The company has licensed the platform of University College London spinout Nanogenics to develop a cancer treatment.
Lou Berneman, founding partner at Osage University Partners, offers his 10 rules for principled negotiation.
LogicBio makes sense of $45m series B
LogicBio is developing treatments for orphan paediatric diseases, based on research conducted at Tel Aviv University, Stanford University and Children’s Medical Research Institute.
Creavo scans $17.5m investment
IP Group has contributed to a funding round for Creavo Medical Technologies, a University of Leeds spinout that has developed a device to quickly check a patient’s cardiac condition.
Zipkin flies to Parker Institute
Takeda Ventures senior investment director Ilan Zipkin has become the second high-profile departure from the unit in four months to join the Parker Institute for Cancer Immunotherapy.
Eloxx, a spinout of Technion – Israel Institute of Technology, has raised a $6m extension for its series C, bringing the round’s total to $30m.
